Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 May-Jun;45(3):190-197.
doi: 10.5144/0256-4947.2025.190. Epub 2025 Jun 5.

Trends in pain management of sickle cell disease patients presenting with acute vasoocclusive crises: a multi-center retrospective study in Saudi Arabia

Saif Musaad Aljuaed  1 , Maan Khalid Jamjoom  2   3   4 , Alaa Mohammed Althubaiti  3   4 , Mohammed Eidhah Alsukhayri  2
Affiliations
Observational Study

Trends in pain management of sickle cell disease patients presenting with acute vasoocclusive crises: a multi-center retrospective study in Saudi Arabia

Saif Musaad Aljuaed et al. Ann Saudi Med. 2025 May-Jun.

Abstract

Background: Sickle cell disease (SCD) is a chronic condition characterized by acute vaso-occlusive crisis (AVOC), which is the primary cause of emergency department (ED) visits for SCD patients. Despite recommendations for opioid use to manage AVOC pain, regional variations and biases in pain management persist, particularly in Saudi Arabia, where the prevalence of SCD varies by region.

Objective: To identify national trends in pain management for AVOC in EDs across Saudi Arabia and analyze the duration and frequency of ED visits.

Design: A multicenter retrospective cohort study.

Settings: Multiple acute care centers in Saudi Arabia under the Ministry of National Guard Health Affairs, including EDs and urgent care centers in Riyadh, Jeddah, Al-Ahsa, Dhahran, and Medina.

Patients and methods: A total of 421 SCD patients presenting with AVOC between 2016 and 2021 were included. Patients with other complications such as infections or acute chest syndrome were excluded. Data on patient demographics, ED visit frequency, length of stay, and medications administered were collected.

Main outcome measures: The primary outcomes were the duration and frequency of ED visits and the types and frequency of analgesics administered.

Sample size: The study included 421 patients accounting for 20 508 ED visits.

Results: The average length of stay per ED visit was 4.7 hours. Morphine was the most frequently used opioid, administered to 86% of patients, while paracetamol was the most commonly used analgesic overall (93%). Regional differences were observed, with less opioid use in the Eastern region, where the disease is less severe due to haplotype variations. Ketamine was used in 13% of cases, predominantly in the Western region.

Conclusions: The study highlights a diverse approach to AVOC management across Saudi Arabia, with variations influenced by regional differences and physician practices. Paracetamol and morphine were the primary analgesics, though disparities in opioid use suggest the need for standardized pain management protocols.

Limitations: This study was limited to centers under one organization and excluded patients with coexisting conditions, which may limit generalizability.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST: None.

Figures

Figure 1.
Figure 1.
Annual ED Visits for AVOC (2016–2021).
Figure 2.
Figure 2.
Number of patients receiving medications by hospital.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Loscalzo J, Fauci A, Kasper D, Hauser S, Longo D, Jameson J, editors.. Harrison's Principles of Internal Medicine. 21st ed. McGraw Hill; 2022.
    1. Centers for Disease Control and Prevention. Complications and treatments of sickle cell disease [Internet]. Atlanta: CDC; 2021. [cited 2021 Feb 22]. Available from: https://www.cdc.gov/ncbddd/sicklecell/treatments.html#Pain
    1. Smith WR, Penberthy LT, Bovbjerg VE, McClish DK, Roberts JD, Dahman BA, et al. Daily assessment of pain in adults with sickle cell disease. Ann Intern Med. 2008;148(2):94–101. doi: 10.7326/0003-4819-148-2-200801150-00004 - DOI - PubMed
    1. Osunkwo I, Andemariam B, Minniti CP, Inusa BPD, Pittman GS, Ibanez V, et al. Impact of sickle cell disease on patients' daily lives, symptoms reported, and disease management strategies: results from the international Sickle Cell World Assessment Survey (SWAY). Am J Hematol. 2021;96(4):404–417. doi: 10.1002/ajh.26063 - DOI - PMC - PubMed
    1. Shah N, Bhor M, Xie L, Paulose J, Yuce H. Sickle cell disease complications: prevalence and resource utilization. PLoS One. 2019;14(7):e0214355. doi: 10.1371/journal.pone.0214355 - DOI - PMC - PubMed

Publication types

LinkOut - more resources